BDNF and early-onset autosomal dominant Alzheimer disease: In contrast to prior reviews, this article synthesizes the findings across multiple studies to provide a comprehensive description of the regulators of BDNF trafficking in the regulated secretory pathway and links these mechanisms to major depressive disorder, schizophrenia, autism spectrum disorders, Huntington’s disease, and Alzheimer’s disease.